Registry study to assess the long-term safety of patients with B lymphocyte malignancies treated with tisagenlecleucel

First published 30/11/2019

Last updated 03/06/2025

EU PAS number:

EUPAS32497

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

ctl019b2401-v02--protocol amendment_Redacted

English (396.27 KB - PDF)View document

Updated protocol

cctl019b2401-v07-protocol amendment_Redacted

First published: 22/02/2024

English (3.15 MB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents